Articles by Adeline Siew, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Adeline Siew, PhD

CPhI Pharma Insights: Formulation and Ingredients Report

The report highlights a need for greater third party certification to ensure GMP vigilance.
Jul 25, 2013

The report highlights a need for greater third party certification to ensure GMP vigilance.

Domino Introduces Fast-Drying Ink for High-Speed Coding

The new ink takes less a second to dry and is four times more fade resistant than inks that are typically used in retail packaging.
Jul 12, 2013

The new ink takes less a second to dry and is four times more fade resistant than inks that are typically used in retail packaging.

Molecular Profiles' New Site Receives MHRA Approval

The new production site is designed to handle a range of non-sterile dosage forms and allow for the manufacture of highly potent compounds.
Jul 12, 2013

Molecular Profiles has opened a new facility in the UK following official approval from MHRA.

Almac Adds Contained Drug Handling and Bottling Capabilities

Almac introduces handling and bottling capabilities in EU and US headquarters.
Jul 3, 2013

Almac introduces handling and bottling capabilities in EU and US headquarters.

Seattle Genetics Forms ADC Pact with Bayer

Seattle Genetics could potentially receive approximately $500 million in fees, milestones and royalties.
Jul 3, 2013

Seattle Genetics could potentially receive approximately $500 million in fees, milestones and royalties.

Controlling Drug Release Through Osmotic Systems

Osmotic systems offer versatility for delivering drugs with varied properties and dosage requirements.
Jul 2, 2013

Osmotic systems offer versatility for delivering drugs with varied properties and dosage requirements.

2013 CPhI Pharma Awards Now Open

Entries open to any company across three categories - formulation, process development and best packaging.
Jun 24, 2013

Entries open to any company across three categories - formulation, process development and best packaging.

EC Fines Lundbeck Over 'Pay-for-Delay' Deals in Europe

Lundbeck and eight other pharmaceutical companies have been fined for delaying generic entry of the blockbuster antidepressant, Celexa (citalopram), into the market.
Jun 21, 2013

Lundbeck and eight other pharmaceutical companies have been fined for delaying generic entry of the blockbuster antidepressant, Celexa (citalopram), into the market.

Industry Perspectives: Achieving Solutions for the Challenge of Poorly Water-Soluble Drugs

A multifaceted approach is needed to resolve the myriad of challenges in developing oral formulations of poorly soluble drugs.
Jun 2, 2013

A multifaceted approach is needed to resolve the myriad of challenges in developing oral formulations of poorly soluble drugs.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here